Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Nicky Whiffin selected as a 2024 Lister Prize Fellow

General

Professor Whiffin is an Associate Professor and Sir Henry Dale Fellow at the Big Data Institute and Centre for Human Genetics at NDM. She is also a Research Fellow at St Anne’s College with the Centre for Personalised Medicine, and a visiting scientist at the Broad Institute of MIT and Harvard.

Genetic variants causing cryptic diseases identified

Researchers from NDM’s Centre for Human Genetics have identified types of genetic variants that lead to a range of rare diseases but are not picked up by standard genetic testing.

Interdisciplinary research provides insights into the genetics of brain asymmetry

Differences between the left and right sides of the nervous system are seen in all animals, including humans. A study by researchers from University College London and NDM’s Division of Structural Biology reveals a new piece in the puzzle of how such asymmetries can arise.

Study highlights importance of ‘junk’ DNA in unlocking diagnosis

A recent study led by the Centre for Human Genetics at NDM has revealed that areas of the human genome that are routinely overlooked in clinical tests may be the cause of some rare diseases.

New identity for Centre

Department General

With the end of Wellcome Trust funding for the Centre, the unit needed a new name and identity, and after consideration it has been decided that it will change to become the Centre for Human Genetics (with the acronym CHG) and adopt a new logo.

Partnership with Danaher paves way for precision medicine test for sepsis

General Research

The University of Oxford today announced a partnership with Danaher Corporation to develop a new test to enable precision medicine care for sepsis, a pathological immune response to infection that accounts for one in five deaths globally each year.

Mexican Biobank launches Mexico’s most complete genetic database to date

A study, done as a part of a joint venture between Mexico’s Cinvestav UGA-Langebio and NDM’s Wellcome Centre for Human Genetics, has revealed an enormously rich tapestry of genetics revealing population histories and diverse genetic make-up of the Mexican population.

Evidence shows COVID-19 triggers sustained inflammatory gene expression

In a study, recently published in Genomics Medicine, researchers from NDM’s Wellcome Centre for Human Genetics and the CAMS Oxford Institute investigated the long-term impact of COVID-19 on immune cells

STRUBI researchers validate IBM’s AI-generated COVID antivirals

In a new study, researchers from IBM and NDM’s Division of Structural Biology and Wellcome Centre for Human Genetics show that new antivirals can be designed with the help of artificial intelligence (AI), developed and potentially validated in month

In Memoriam: Professor Dominic Kwiatkowski

Department

We regret to announce the passing of Professor Dominic Kwiatkowski, Professor of Tropical Paediatrics at the Nuffield Department of Medicine, and a renowned researcher who dedicated his life to the research on malaria. Prof Kwiatkowski passed away in April 2023 at the age of 69.

Genetic signals causing ankylosing spondylitis uncovered in a new study

Research

A study by Nuffield Department of Medicine’s Wellcome Centre for Human Genetics, and collaborating researchers have uncovered the genetic signals that cause ankylosing spondylitis, a type of spinal arthritis.

New study reveals significant clues for targeted therapies for sepsis

Research

Researchers from NDM’s Wellcome Centre for Human Genetics and the Queen Mary University have found evidence of how the normally protective response of the immune system to infection can go wrong in sepsis, offering exciting possibilities for the development of more targeted therapies for this deadly condition.

Stanley Ho Foundation supports the CPM

The Centre for Personalised Medicine has received a further 7 years of financial support from the Stanley Ho Foundation.

New genetic mutation linked to rare conditions

Researchers from Wellcome Centre for Human Genetics at the Nuffield Department of Medicine, have discovered that a rare type of genetic variant can be responsible for two well-known skeletal disorders.

Leedham Lab receives funding to improve bowel cancer treatments

The Leedham Lab at the Wellcome Centre for Human Genetics in the Nuffield Department of Medicine (NDM) has been awarded over £2m from Cancer Research UK to develop a new tool that could help guide how bowel cancer patients are treated in the future.

Load More